Psoromic Acid Derivatives: A New Family of Small-Molecule Pre-mRNA Splicing Inhibitors Discovered by a Stage-Specific High-Throughput in Vitro Splicing Assay
Open Access
- 14 February 2012
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 13 (5) , 640-644
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Genetic therapies for RNA mis-splicing diseasesTrends in Genetics, 2011
- The Spliceosome: Design Principles of a Dynamic RNP MachineCell, 2009
- Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylationRNA, 2008
- The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA SplicingJournal of Biological Chemistry, 2008
- Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNANature Chemical Biology, 2007
- Splicing factor SF3b as a target of the antitumor natural product pladienolideNature Chemical Biology, 2007
- The spliceosome: a novel multi-faceted target for therapyTrends in Biochemical Sciences, 2005
- Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin DerivativesMolecular Pharmacology, 2005
- Novel RNAs Identified From an In-Depth Analysis of the Transcriptome of Human Chromosomes 21 and 22Genome Research, 2004
- Inhibition of nuclear pre‐mRNA splicing by antibiotics in vitroEuropean Journal of Biochemistry, 2002